BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37350470)

  • 1. Optimal vaccination strategies for COVID-19 in population migration between two regions scenario.
    Zuo C; Ling Y; Guo Y; Zhang M; Meng Z; Xiang G
    Hum Vaccin Immunother; 2023 Aug; 19(2):2223108. PubMed ID: 37350470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of health-oriented cross-regional allocation strategies for the COVID-19 vaccine: a mathematical modelling study.
    Yang T; Deng W; Liu Y; Deng J
    Ann Med; 2022 Dec; 54(1):941-952. PubMed ID: 35393922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.
    Miura F; Leung KY; Klinkenberg D; Ainslie KEC; Wallinga J
    PLoS Comput Biol; 2021 Dec; 17(12):e1009697. PubMed ID: 34898617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing vaccine allocation at different points in time during an epidemic.
    Matrajt L; Longini IM
    PLoS One; 2010 Nov; 5(11):e13767. PubMed ID: 21085686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal H1N1 vaccination strategies based on self-interest versus group interest.
    Shim E; Meyers LA; Galvani AP
    BMC Public Health; 2011 Feb; 11 Suppl 1(Suppl 1):S4. PubMed ID: 21356133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal allocation of limited vaccine to control an infectious disease: Simple analytical conditions.
    Rao IJ; Brandeau ML
    Math Biosci; 2021 Jul; 337():108621. PubMed ID: 33915160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing Spatio-Temporal Allocation of the COVID-19 Vaccine Under Different Epidemiological Landscapes.
    Cao W; Zhu J; Wang X; Tong X; Tian Y; Dai H; Ma Z
    Front Public Health; 2022; 10():921855. PubMed ID: 35812517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal control of vaccination dynamics during an influenza epidemic.
    Jaberi-Douraki M; Moghadas SM
    Math Biosci Eng; 2014 Oct; 11(5):1045-63. PubMed ID: 25347806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study.
    Wang T; Li C; Li H; Li Z
    BMJ Open; 2022 Jul; 12(7):e057281. PubMed ID: 35831042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal resource allocation with spatiotemporal transmission discovery for effective disease control.
    Ren J; Liu M; Liu Y; Liu J
    Infect Dis Poverty; 2022 Mar; 11(1):34. PubMed ID: 35331329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.
    Zhu J; Wang Q; Huang M
    Front Public Health; 2023; 11():1129183. PubMed ID: 37168073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrupt transition of the efficient vaccination strategy in a population with heterogeneous fatality rates.
    Jhun B; Choi H
    Chaos; 2022 Sep; 32(9):093140. PubMed ID: 36182386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to Resurgent COVID-19 Outbreaks Following Vaccine Rollouts: A Modeling Study.
    Neofotistos G; Angeli M; Mattheakis M; Kaxiras E
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study.
    Vilches TN; Abdollahi E; Cipriano LE; Haworth-Brockman M; Keynan Y; Sheffield H; Langley JM; Moghadas SM
    BMC Public Health; 2022 May; 22(1):1042. PubMed ID: 35614429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal control of the spatial allocation of COVID-19 vaccines: Italy as a case study.
    Lemaitre JC; Pasetto D; Zanon M; Bertuzzo E; Mari L; Miccoli S; Casagrandi R; Gatto M; Rinaldo A
    PLoS Comput Biol; 2022 Jul; 18(7):e1010237. PubMed ID: 35802755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of infection fatality ratio and social contact matrices on vaccine prioritization strategies.
    Schulenburg A; Cota W; Costa GS; Ferreira SC
    Chaos; 2022 Sep; 32(9):093102. PubMed ID: 36182373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal control-based vaccination and testing strategies for COVID-19.
    Olivares A; Staffetti E
    Comput Methods Programs Biomed; 2021 Nov; 211():106411. PubMed ID: 34600408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling epidemics with fractional-dose vaccination in response to limited vaccine supply.
    Chen Z; Liu K; Liu X; Lou Y
    J Theor Biol; 2020 Feb; 486():110085. PubMed ID: 31758966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.